Three-times-weekly vs Daily Iron Supplementation for primary prevention of Anemia in Pregnancy Living in Urban Area; An open-label, Randomized Controlled Trial
- Conditions
- Anemia in PregnancyAnemia in Pregnancy,iron deficiency anemia,anemia,iron supplement,pregnancy
- Registration Number
- TCTR20201013004
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 136
- Age >= 18 year-old
- singleton
- < 14 week gestational age
- Hb >= 11 mg/dL, mcv >= 80, DCIP - negative
- no thyroid disorder
- no history of Triferdine allergy
- understand and well-communicate Thai
- previous iron supplement in this pregnancy
- previous blood transfusion
- abnormal bleeding from any sites
- thalassemia traits/disease or thyroid disorder
- smoking or chronic lung disease
- iron, iodine or folic acid allergy
- poor compliance
- aborted or delivered before 28 week-gestation
- Forgot to take Triferdine more than 80%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method